CAR-T Collaboration Covalab has capability to design full length antibodies and fragments such as scFv, VHH, and Fab for use in CAR-T therapies, plus experience with cancer biomarkers and gene vectors, positioning the company to partner with biotech firms developing CAR-T products for research and preclinical testing.

Diagnostics Partnerships Proven history of developing antibodies for autoimmune diseases and cerebral protein aggregates, along with kit ready offerings and labeling services, enables Covalab to partner with diagnostic developers to supply antibodies, immunogens, and assay components for new autoimmune or neurodegenerative tests.

Agro Food Solutions Experience in complete diagnostic kits for mycotoxins, phycotoxins, pesticides, and polyaromatic hydrocarbons, with validated antibodies and modified immunogens, creates opportunities to license or co-develop comprehensive food safety tests with agro food industry players and distributors.

Custom Antibody Services Offering antibody engineering across polyclonal, monoclonal, scFv and VHH, plus purification, labeling, and peptide synthesis for research use, supported by decades of antigen and antibody modification experience, presents a strong value proposition for CROs and academic labs needing custom antibodies, conjugates, and antigen design.

Distributor Partnerships Existing distributor network and manufacturing capabilities position Covalab to accelerate market penetration by expanding partner programs, offering co marketing, and ensuring scalable logistics for antibodies, kits, and custom services.